Founded in San Antonio, Texas, Seno Medical Instruments specializes in the commercialization of opto-acoustic imaging technology for breast cancer detection. The company's core mission is to improve the accuracy and efficiency of breast cancer diagnostics, thereby enhancing patient outcomes. Seno Medical's flagship product, the Imagio® Breast Imaging System, combines opto-acoustic and ultrasound imaging to provide a more comprehensive view of breast tissue, aiming to reduce the need for biopsies and improve diagnostic confidence.

Seno Medical has garnered attention from notable investors and medical professionals who support its innovative approach to breast cancer diagnostics. The company has achieved significant milestones, including FDA approval for its Imagio® system, which underscores its impact on the medical imaging market. By advancing breast cancer detection technology, Seno Medical is making a meaningful contribution to women's health and the broader field of medical diagnostics.